ALLUCENT
Allucent develops a cloud-based short-term scheduling application for the construction industry. It integrates scheduling and project management systems into a collaborative scheduling platform. Allucent pulls data from and pushes data to the master schedule, allows for schedule updates from the field, tracks productivity rates, prioritizes project documents based on the schedule, and allows users to see the health of the project at a glance.
ALLUCENT
Industry:
Cloud Data Services Construction Database Productivity Tools Project Management SaaS Software
Founded:
2018-01-01
Address:
Rexburg, Idaho, United States
Country:
United States
Website Url:
http://www.allucent.io
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location
Similar Organizations
Appward
Appward delivers a set of over 80 apps to help you manage projects, CRM, employees, operations, quality, manufacturing and supply chain.
BlueRithm
BlueRithm is a cloud-based software for managing commissioning, test and balance, QA/QC, inspections, and other systems-based projects.
BuilderPad
BuilderPad is a modern, customer-centric app for home builders.
Encore Group
Encore Group offers project management solutions, scheduling, claims management, and software for the construction industry.
goDeskless
goDeskless is a cloud-based workforce automation platform specially designed for the "deskless workforce".
Reniac
Reniac is a group of passionate entrepreneurs with data, software and systems experience from companies.
Trax
Trax is a software company that enriches building codes for the design and construction industry.
Viewpoint
Viewpoint is a collaborative project management solution company, builds Integrated construction management software.
Current Employees Featured
Founder
Official Site Inspections
http://www.allucent.io Semrush global rank: 11.77 M Semrush visits lastest month: 148
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Allucent"
About Us — allucent
Allucent is a cloud-based construction scheduling software designed to optimize existing methods and approaches. It's easy to master for swift and scalable implementation. Unlike other …See details»
Home | Allucent
Allucent is a full-service Clinical Research Organization dedicated to providing high quality solutions for small to mid-sized biotechs.See details»
About Us - Allucent
A Fully Integrated Global Company Today, Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid …See details»
Allucent - Crunchbase Company Profile & Funding
Allucent develops a cloud-based short-term scheduling application for the construction industry.See details»
Solutions - Allucent
A-Team Expertise, Tailored for You As a Contract Research Organization (CRO) focused on the distinct needs of small and mid-sized biotech companies, Allucent has one purpose – helping you succeed across the drug development journey. …See details»
Allucent Names Paula Brown Stafford as CEO - Yahoo Finance
Jul 23, 2024 Paula Brown Stafford joins Allucent in a planned leadership transition, bringing 35+ years of life science experience, including with Quintiles and Novan, Inc., to guide company's …See details»
Allucent - LinkedIn
Allucent | 88,428 followers on LinkedIn. Helping bring new therapies to light | Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid …See details»
Allucent - LinkedIn
Today, Allucent is a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics and clinical pharmacology across a variety of therapeutic areas.See details»
Allucent - LinkedIn India
Allucent | 89,126 followers on LinkedIn. Helping bring new therapies to light | Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid …See details»
Allucent Receives BARDA-Funded Project NextGen Award to …
May 15, 2024 Allucent, a global mid-sized clinical research organization (CRO), announced today that it received a project award valued at $25.5 million through the Rapid Response …See details»
History - Allucent
Company Origins In the spring of 2022, Allucent came into being with the merger of several high-performance companies serving the specialized needs of small and mid-sized biotechs. …See details»
Solutions — allucent
We wholeheartedly understand the unique challenges that construction professionals both bring and face daily. Our comprehensive solutions are trade validated to cut planning sessions down …See details»
Allucent Chairman and CEO Mark A. Goldberg Honored by …
September 6, 2022 – Global biopharmaceutical services leader, Allucent, announced today that its Chairman and CEO, Mark A. Goldberg, M.D., has been named to the PharmaVoice 100 …See details»
Mission, Vision and Values - Allucent
Our Mission Utilizing experience driven insights and innovative solutions, we are passionate about helping clients successfully navigate drug development and regulatory complexities.See details»
Allucent Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Allucent. Use the PitchBook Platform to explore the full profile.See details»
Allucent Awarded 5-Year BARDA Agreement Aimed at Enhancing …
Jul 9, 2024 Allucent, a global mid-sized clinical research organization (CRO), announced today that it has been selected by the Biomedical Advanced Research and Development Authority …See details»
Allucent Recognized with CRO Leadership Awards for Expertise …
May 2, 2024 Allucent, a global mid-sized clinical research organization (CRO), received two CRO Leadership Awards presented by Clinical Leader and Life Science Connect for the …See details»
Allucent selected for new BARDA decentralized trial initiative
Jul 10, 2024 Allucent was selected for a new five-year BARDA program that aims to scale up the capacity for decentralized clinical trials in future pandemics.See details»
Oncology & Hematology - Allucent
Oncology remains one of the most challenging therapeutic areas, with the lowest success rates in clinical trials. This underscores the need for innovative strategies and a partner who …See details»